Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/20 17:28 | 3/24/20 | NTGN | Health | BioPrd | Biological Products, (No Diag | Access Industries Holdings LLC | NY | T | S.m | -553 | 2.19 | 0 | -252 | -8 | 2,837 | M | |||||||||||||||
3/23/20 21:00 | 3/20/20 | NTGN | Health | BioPrd | Biological Products, (No Diag | Access Industries Holdings LLC | NY | T | S.m | -210 | 2.25 | 0 | -93 | -3 | 3,005 | M | |||||||||||||||
11/27/19 17:01 | 11/25/19 | NTGN | Health | BioPrd | Biological Products, (No Diag | Gaynor Richard | MA | O | P of R,D | S.m | -85 | 1.31 | 0 | -65 | -29 | 157 | D | ||||||||||||||
8/22/18 16:18 | 8/20/18 | NTGN | Health | BioPrd | Biological Products, (No Diag | O'Dowd Hugh | MA | DO | P,CEO | M.d | 50 | 2.65 | 0 | 19 | 4 | 446 | D | ||||||||||||||
7/18/18 16:38 | 7/17/18 | NTGN | Health | BioPrd | Biological Products, (No Diag | Al-Wakeel Yasir B. | MA | O | CFO | M.d | 100 | 5.80 | 0 | 17 | New | 17 | D | ||||||||||||||
7/3/18 14:10 | 6/29/18 | NTGN | Health | BioPrd | Biological Products, (No Diag | Access Industries Holdings LLC | NY | T | P.d | 5,040 | 16.00 | 0 | 315 | 11 | 3,098 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |